FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live LALPATHLAB message board: Is LALPATHLAB buy or sell? Should I buy LALPATHLAB shares? Why are LALPATHLAB shares falling? Should I invest in LALPATHLAB stock?
forum
LALPATHLAB Share Price Discussion
Dr. Lal Path Labs Ltd.
NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Sector: Pharmaceuticals and health care
N
Reputation: 3,957 • May 9 1:43 AM
Opportunity is pharma is huge, advise investors to invest: Motilal Oswal
As lockdown mode could continue and the government's ability to come out with an aggressive bailout package is limited, it's difficult to make out a case for big upside in the short run.
As lockdown mode could continue and the government's ability to come out with an aggressive bailout package is limited, it's difficult to make out a case for big upside in the short run.
Moneycontrol
Like
Reply
NSE:LALPATHLAB price when posted: 1,560
Recent posts in LALPATHLAB
N
Reputation: 3,957 • Today 10:08 AM
Outlook for diagnostics industry favourable for growth: Dr Lal PathLabs
The company, in its Annual Report for 2019-20, stated that instances and situations like the COVID-19 outbreak further boost the importance of diagnostics as an integral part of healthcare system.
The company, in its Annual Report for 2019-20, stated that instances and situations like the COVID-19 outbreak further boost the importance of diagnostics as an integral part of healthcare system.
Moneycontrol
Like
Reply
N
Reputation: 3,957 • Today 9:36 AM
Outlook for diagnostics industry favourable for growth: Dr Lal PathLabs
The company said it served 1.94 crore patients and processed 4.77 crore samples
The company said it served 1.94 crore patients and processed 4.77 crore samples
The Economic Times
Like
Reply
N
Reputation: 3,957 • Jul 5 6:33 AM
'These tech companies will continue to generate greater returns in future'
I think most pharma stocks are overvalued now, and the rally will stablise now, says Sumit Bilgaiyan, the founder of Equity99.
I think most pharma stocks are overvalued now, and the rally will stablise now, says Sumit Bilgaiyan, the founder of Equity99.
Moneycontrol
Like
Reply
D
Reputation: 17,531 • May 19 5:00 AM
Prabhudas Lilladher target on LALPATHLAB
Date: 19-May-20
Broker: Prabhudas Lilladher
Price @ Call: 1583.35
Target: 895
Recommendation: SELL
Like
Reply